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ABSTRACT 
Recent development in fast disintegrating technology mainly works to improve the quality of these delicate dosage forms without 
affecting their integrity. Current investigations deal with the formulation of fast dissolving tablet of Ondansetron HCl with the effect 
of different co-processed excipients by using ball mill that disintegrates in oral cavity on contact with saliva & thereby improve 
therapeutic efficacy because the mannitol was stick to dies and punch therefore ball mill is used to prepare co ground mixtures of 
crospovidone and mannitol to improve the compatibility and stability of product. The Fast disintegrating tablets of Ondansetron HCl 
were prepared by direct compression method using different synthetic superdisintegrant such as Crospovidone, and 
natural superdisintegranst such as Karaya gum and Fenugreek gum in different concentration. The FTIR, DSC analysis revealed that 
the Betacyclodextrin and superdisintegrants used were compatible with Ondansetron HCl. A complex of Betacyclodextrin and 
Ondansetron HCl was successfully formed in 1:2 ratios. Disintegration time decrease with increase in the concentration 
o superdisintegrant. Among all formulation, containing Karaya Gum as superdisintegrants is fulfilling all the parameters 
satisfactorily. In vitro release studies that almost 98.88% of the drug was released from all the formulation were within 15 minutes. 
Best Formulation F6 showed faster drug release within 7 minutes in comparison to other formulation. ThE result shows that Co-
processing of excipients is the most suitable approach for formulation of Fast dissolving tablet. 
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INTRODUCTION 
United States Food and drug administration defined fast 
disintegrating tablet as “a solid dosage form containing 
medicinal substance or active ingredient which 
disintegrate   fast usually within a few seconds when 
placed upon the tongue.” FDTs differ from traditional 
tablets as they are designed to be dissolved on the 
tongue rather than swallowed whole. Fast disintegrating 
tablets are also known as mouth disintegrating tablets, 
melt-in mouth tablets, Orodispersible tablets, porous 
tablets, quick dissolving tablets, fast dissolving tablets.
1
 
According to US Food and Drug Administration 2008 
publications of guidance are: FDTs should have an In 
vitro disintegrating time of approximately 30 sec or 
less.
2
 Generally, the FDT tablet weight should not 
exceed 500 mg, although the combine influence of 
stable weight, size and component solubility all factor 
into the acceptability of an ODT for both patients and 
regulators. Recent advances in novel drug delivery 
system aim to enhance safety and toxicity of drug 
molecules by formulating a convenient dosage form for 
administration and to achieve better patient compliance.
4
 
One such approach led to development of fast dissolving 
tablets. Fast dissolving drug-delivery systems were first 
developed in the late 1970s as an alternative to 
conventional dosage forms for paediatric and geriatric 
patient. Traditional tablets and capsules administered 
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with an 8-oz. glass of water may be inconvenient or 
impractical for some patients who experience difficulties 
in swallowing traditional oral solid-dosage forms. These 
tablets are designed to dissolve or disintegrate rapidly in 
the saliva generally less than 60 seconds
.5
 
Coprocessed Excipients
6 
Co-processing is based on the novel concept of two or 
more excipients interacting at the sub particle level, the 
objective of which is to provide a synergy of 
functionality improvement as well as masking the 
undesirable properties of individual. Co-processing 
excipients leads to the formulation of excipient granules 
with superior properties compared with physical 
mixtures of components or individual components. The 
resulting engineered excipients are commonly known as 
“coprocessed,” “high functionality,” “multifunctional,” 
“high functionality,” “performance” excipients.7 
Significance of the co-processed excipients 
1. Enhancement in flow properties 
2. Absence of chemical change 
3. Better dilution potential 
4. Fill weight variation 
5. Reduced lubricant sensitivity 
6. Improved compressibility
8 
All coprocessed and modified excipients are playing 
very important role in the development of easy dosage 
form. Compared with existing excipients, the improved 
physical, mechanical, and chemical properties of such 
excipients have helped in solving formulation problems 
such as flow ability, compressibility, hygroscopicity, 
palatability, dissolution, disintegration, sticking, and 
dust generation. There is need to develop  new specially 
designed equipment for  evaluations of coprocessed  
excipients &  Coprocessed excipients have yet to find 
their way into official monographs, also we can explore 
coprocessed excipients in various drug deliveries.
9,10 
MATERIALS AND METHOD 
Ondansetron HCl was obtained as a gift sample 
Maxheal Pharmaceuticals, MIDC, Nashik 
Crospovidone, Karaya gum, Fenugreek gum, Sodium 
bicarbonate, Microcrystalline cellulose, Flavor 
,Mannitol, Aspartame ,Mg. stearate, Talc, Beta 
cyclodextrin. From Research Lab Fine Chem. Ltd. 
Mumbai.  
Methods: 
 1. Preformulation study 
a) Identification and characterization of Ondansetron 
HCl 
 b) Determination of Melting point: The melting point of 
the drug was determined using capillary tube.  
 c) Calibration Curve in 6.8 Phosphate Buffer:  
 d) Compatibility Study of Drug and Excipients: 
 i) FTIR spectrum 
ii) DSC 
2. Preparation of drug and BCD complex by 
kneading method:  
A mixture of Ondansetron HCl and Betacyclodextrin 
was ground in a glass container and a minimum amount 
of water was added. The mixture was kneading for 5 
min and dried at 60°C in the vacuum oven. After drying 
inclusion complex of Ondansetron HCl and β-
cyclodextrin was obtained. 
3. Preparation of coprecessed co-ground mixture for 
FDTS by using ball mill 
Coground Mixture and FDTs Coground mixtures 
prepared by using a ball mill. The Coground mixtures 
were blended with drug, mannitol, and magnesium 
stearate in a glass bottle using manual shaking. After 
blending, the mixtures were compressed using a single 
tableting machine. The purpose of this study was to 
prepare oral fast disintegrating tablets (OFDTs) by 
directly compressing a mixture of mannitol and 
Crospovidone .When the mixture of mannitol and 
Crospovidone was co-processed by ball mill .To 
improve the compatibility and their stability during 
storage. The (OFDTs) without this co-processing, the 
powder mixture had poor compatibility, and the stability 
of the tablet was inferior, probably due to the high 
Hygroscopicity of Crospovidone. The OFDTs 
containing co-ground mixture of crospovidone/mannitol 
showed good stability for six months under humid 
conditions with rapid disintegration and increase 
hardness of the tablets Tablet stability could not be 
achieved using a physical mixture of 
crospovidone/mannitol without including the co-ground 
process.
11,12 
4. Formulation of oral fast disintegrating tablets 
The best batch obtained from Kneading method with 1:2 
ratio of inclusion complex was prepared by direct 
compression method containing 12 mg of Ondansetron. 
Drug + Beta cyclodextrin inclusion complex equivalent 
to 4mg of Ondansetron was taken and pass through the # 
40. Diluents, superdisintegrants, sweetener and flavour 
were passed through # 40. All above ingredients were 
mixed and blended properly. Magnesium stearate was 
passed through # 40 and mixed properly with above 
blend. Powdered lubricated blend was compressed into 
tablet by Rimek, minipress-2
nd
 DL 09 station tooling 
machine using, 7 mm round flat punches. 
 
 
 
 
Table 1: Composition of Oral Fast disintegrating tablets of Ondansetron HCl 
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*All the quantities mentioned above in mg 
 
5. Evaluation of oral fast disintegrating tablets 
a) Weight variation: Average weight of 20 tablets were 
selected randomly from the lot and weighed individually 
to check for weight variation. 
b) Tablet Thickness: Ten tablets were taken and their 
thickness was recorded using Vanier calliper. It is 
measured in mm  
c) Tablet Hardness: Hardness of the tablet of each 
formulation was determined using Monsatoo hardness 
tester.  
 d) Friability (F): Friability of the tablet is determined 
using Roche friabilator. This device subjects the tablet 
to the combined effect of abrasion and shock in a plastic 
chamber revolving at 25 rpm and dropping a tablet at a 
height of 6 inches in each revolution. Pre weighed 
sample of tablets was placed in the friabilator and were 
subjected to the 100 revolutions. Tablets were dusted 
using a soft muslin cloth and reweighed. The friability 
(F) is given by the formula. 
%Friability = loss in weight / Initial weight x 100 
e) Wetting Time: The wetting time of the tablets can be 
measured using a simple procedure. Twice folded 
circular tissue papers of 10 cm diameter were placed in a 
Petridis with a 10 cm diameter.10 ml of pH 6.8 
phosphate buffer. A tablet is carefully placed on the 
surface of the tissue paper. The time required for 
phosphate buffer to reach upper surface of the tablet is 
noted as a wetting time.
 
 f)Water Absorption Ratio: A piece of tissue paper 
folded twice was placed in a small Petri dish containing 
6 ml of pH 6.8 phosphate buffer. A tablet was put on the 
tissue paper and allowed to completely wet. The wetted 
tablet was then weighed. Water absorption ratio, R was 
determined using following equation.
 
R = 100 × (Wa –Wb)/Wa 
Where, Wa = Weight of tablet after water absorption 
Wb = Weight of tablet before water absorption. 
g) In vitro dispersion time: In vitro dispersion time 
was measured by dropping a tablet in a 10 ml measuring 
cylinder containing 6 ml of buffer solution simulating 
saliva fluid (pH 6.8) at 37 ± 0.5ºC and the time required 
for complete dispersion was determined.
 
h) Content Uniformity: The content uniformity of the 
prepared formulas orodispersible tablets was performed 
by taking ten tablets and assayed individually. The 
requirement for this test is met if the amount of 
ingredient in each of the ten tablets lies within the range 
of 95%-102%.Taken five tablets were powered and the 
blend equivalent to 20 mg of Ondansetron was weight 
and dissolved in 100 ml of phosphate buffer (pH 6.8). 
Stock solutions are sonicted for 14 minute. Filter the 
sample and withdraw 1ml filtrate was taken in25 ml 
phosphate buffer (pH 6.8) and analyzed 
spectrophotometrically at 310 nm. The amount of 
Ondansetron was estimated by using standard 
calibration curve of drug 
RESULT AND DISCUSSION 
Identification and Characterisation of Ondansetron 
HCl 
Melting Point 
The melting point of the Ondansetron HCl was found to 
be 231
0
C, which complies with BP. 
 
Standard calibration curve of Ondansetron HCl
 
FTIR Analysis: 
y = 0.1569x - 0.167 
R² = 0.9991 
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Ingredients 
F1 
(mg) 
F2 
(mg) 
F3 
(mg) 
F4 
(mg) 
F5 
(mg) 
F6 
(mg) 
F7 
(mg) 
F8 
(mg) 
F9 
(mg) 
OSH+BCD complex 
(equivalent to 4mg Drug) (1:2) 
12 12 12 12 12 12 12 12 12 
 Fenugreek Gum 4 8 10 - - - - - - 
 Karaya Gum - - - 4 8 10 - - - 
 Crospovidone - - - - - - 4 8 10 
 Avicel 101 55.5 55.5 55.5 55.5 55.5 55.5 55.5 55.5 55.5 
Magnesium Stearate 3 3 3 3 3 3 3 3 3 
 Talc 3 3 3 3 3 3 3 3 3 
 Orange flavor 1 1 1 1 1 1 1 1 1 
Aspartame 2 2 2 2 2 2 2 2 2 
Mannitol QS QS QS QS QS QS QS QS QS 
 Total weight 150 150 150 150 150 150 150 150 150 
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Figure 1: FTIR spectrum of Ondansetron HCL 
 
Figure 2: FTIR spectrum of Ondansetron HCL with cyclodextrin complex 
 
Figure 3: FTIR spectrum of Ondansetron HCL in powder blend 
From FTIR study it can concluded that the drug Ondensetron HCL have maintained its identity without losing its 
characteristic properties. 
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Figure 4: Differential Scanning Calorimetry of Ondansetron HCl 
 
 
Figure 5: Differential Scanning Calorimetry of Ondansetron HCl with    Excipients 
The DSC thermogram of Ondencetron Fig.4 and Losartan Potassium Fig.5 exhibited a single sharp endothermic peak at 
230
o 
C respectively, related to its melting transition temperature. 
 
Table 2: Post-compression parameter of batches F1-F9 
Formulation Thickness (n=3) 
(mm)(SD) 
Hardness 
(kg/cm
2
) (n=3) (SD) 
Friability 
(%) 
Weight Variation 
(n=20)(mg) (SD) 
F1 2.49± 0.2 3.13 ± 0.04 0.81 Passable 
F2 2.95± 0.1 2.99 ± 0.04 0.45 Passable 
F3 2.43± 0.3 3.02 ± 0.06 0.71 Passable 
F4 2.58± 0.2 3.04 ± 0.31 0.64 Passable 
F5 2.56± 0.2 2.84 ± 0.04 0.56 Passable 
F6 3.03± 0.3 3.45 ± 0.09 0.80 Passable 
F7 3.02±0.3 2.90± 0.02 0.33 Passable 
F8 3.06± 0.2 3.00 ± 0.02 0.66 Passable 
F9 2.67± 0.1 2.89 ± 0.05 0.75 Passable 
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Table 3: Other Post-Compression parameters of batches F1-F9    
 
In vitro Dissolution study of formulation batches F1-F9 
 
Figure 6: Comparative in vitro release profile of 
Ondansetron HCl Fast disintegrating tablets for 
formulation F1to F3 
 
Figure 7: Comparative in vitro release profile of 
Ondansetron HCl Fast disintegrating tablets for 
formulation F4 to F6. 
 
Figure 8: Comparative in vitro release profile of 
Ondansetron HCl Fast disintegrating tablets for 
formulation F7 to F9 
CONCLUSION 
The Fast disintegrating tablets of Ondansetron HCl were 
prepared by direct compression method using different 
superdisintegrant such as Crospovidone,   Karaya gum 
and Fenugreek gum in different concentration with help 
of ball mill for coprocessing. The mannitol was stick to 
dies and punch therefore ball mill is use to prepare 
coground mixtures of crospovidone and mannitol to 
improve the compatibility and stability of product. The 
FTIR, DSC analysis revealed that the Betacyclodextrin 
and polymer used were compatible with Ondansetron 
HCl. Disintegration time decrease with increase in the 
concentration of superdisintegrant. Among all 
formulation, containing Karaya Gum as 
superdisintegrants is fulfilling all the parameters 
satisfactorily. In vitro release studies that almost 98.88% 
of drug was release from all the formulation were within 
15 minutes. Formulation F6 showed faster drug release 
within 7 minutes in comparison to other 
formulation.Thus result shows that Co-processing of 
excipients is most suitable approach for formulation of 
Fast dissolving tablet. 
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Time (min) 
F4 F5 F6 
Formulation Wetting time (Sec) Water absorption Ratio (SD) Dispersion Time (sec) (SD) 
F1 44 53± 0.2 33 ± 0.2 
F2 36 55± 0.1 34± 0.3 
F3 39 64± 0.5 34 ± 0.2 
F4 42 62± 0.2 43  ± 0.5 
F5 49 54± 0.2 50 ± 0.4 
F6 43 63± 0.6 46 ± 0.2 
F7 38 53± 0.1 33 ± 0.4 
F8 35 62± 0.4 32± 0.4 
F9 43 58± 0.4 66 ± 0.6 
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